Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that it enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2023 conducted after the meeting of Board of Directors held on May 25, 2023. The above information has been uploaded on the Company's website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release
The above information is a part of company’s filings submitted to BSE.
